MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
Atara Biotherapeutics Historical Prices 2011-2026 | ATRA
Annual Historical Prices Atara Biotherapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.81 | 0.69 | 5.09 | 15.8 | 19.6 | 16.5 | 34.7 | 18.1 | 14.2 | 26.4 | 26.8 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 34.7 | 0.69 | 16.8 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M |  Germany |
 |
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M |  USA |
 |
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | USA |
 |
ADMA Biologics
ADMA
|
15.9 | $ 15.87 | -4.08 % | $ 3.78 B | USA |
 |
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M | USA |
 |
AbCellera Biologics
ABCL
|
3.22 | $ 3.54 | -2.62 % | $ 1.06 B |  Canada |
 |
I-Mab
IMAB
|
0.68 | - | - | $ 866 M |  China |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M |  France |
 |
Aptorum Group Limited
APM
|
0.75 | $ 0.82 | -0.73 % | $ 4.47 M | China |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | USA |
 |
Alpine Immune Sciences
ALPN
|
8.04 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | USA |
 |
Apellis Pharmaceuticals
APLS
|
22 | $ 20.36 | 2.49 % | $ 2.57 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | USA |
 |
ANI Pharmaceuticals
ANIP
|
61.9 | $ 75.13 | -1.83 % | $ 1.45 B | USA |
 |
Applied Therapeutics
APLT
|
6.42 | - | - | $ 8.42 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
1.66 | $ 1.51 | -7.36 % | $ 385 M | Britain |
 |
Aravive
ARAV
|
1.66 | - | -13.39 % | $ 1.45 M | USA |
 |
Adverum Biotechnologies
ADVM
|
3.86 | - | - | $ 86.2 M | USA |
 |
Athersys
ATHX
|
0.9 | - | 3.77 % | $ 22.4 M | USA |
 |
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | USA |
 |
AVEO Pharmaceuticals
AVEO
|
3.54 | - | - | $ 521 M | USA |
 |
Axsome Therapeutics
AXSM
|
174 | $ 162.19 | -1.15 % | $ 8.07 B | USA |
 |
BridgeBio Pharma
BBIO
|
68.4 | $ 64.72 | -2.73 % | $ 12.4 B | USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
1.26 | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
3.1 | - | -4.8 % | $ 255 M | USA |
 |
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M | Canada |
 |
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Bellicum Pharmaceuticals
BLCM
|
0.27 | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
1.7 | - | -7.31 % | $ 87 M | USA |
 |
CureVac N.V.
CVAC
|
19.3 | - | - | $ 867 M | Germany |
 |
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | Canada |
 |
Bellerophon Therapeutics
BLPH
|
8.23 | - | -74.18 % | $ 955 K | USA |
 |
BioLineRx Ltd.
BLRX
|
2.65 | $ 2.86 | 1.78 % | $ 908 M |  Israel |
 |
BioMarin Pharmaceutical
BMRN
|
61 | $ 60.15 | -0.46 % | $ 11.5 B | USA |
 |
Equillium
EQ
|
2.44 | $ 1.7 | -3.14 % | $ 59 M | USA |
 |
Burford Capital Limited
BUR
|
10.6 | $ 8.29 | -1.02 % | $ 1.35 B | Britain |
 |
Cabaletta Bio
CABA
|
17.5 | $ 3.3 | -3.89 % | $ 3.85 M | USA |
 |
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | USA |
 |
Agenus
AGEN
|
0.6 | $ 3.02 | -5.63 % | $ 1.08 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M | Israel |
 |
Capricor Therapeutics
CAPR
|
5.8 | $ 25.16 | -1.33 % | $ 674 M | USA |
 |
Agios Pharmaceuticals
AGIO
|
28.1 | $ 27.77 | -1.49 % | $ 1.61 B | USA |